Browse > Article
http://dx.doi.org/10.5483/BMBRep.2018.51.10.051

Facile analysis of protein-protein interactions in living cells by enriched visualization of the p-body  

Choi, Miri (Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology)
Baek, Jiyeon (Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology)
Han, Sang-Bae (College of Pharmacy, Chungbuk National University)
Cho, Sungchan (Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology)
Publication Information
BMB Reports / v.51, no.10, 2018 , pp. 526-531 More about this Journal
Abstract
Protein-Protein Interactions (PPIs) play essential roles in diverse biological processes and their misregulations are associated with a wide range of diseases. Especially, the growing attention to PPIs as a new class of therapeutic target is increasing the need for an efficient method of cell-based PPI analysis. Thus, we newly developed a robust PPI assay (SeePPI) based on the co-translocation of interacting proteins to the discrete subcellular compartment 'processing body' (p-body) inside living cells, enabling a facile analysis of PPI by the enriched fluorescent signal. The feasibility and strength of SeePPI (${\underline{S}}ignal$ ${\underline{e}}nhancement$ ${\underline{e}}xclusively$ on ${\underline{P}}-body$ for ${\underline{P}}rotein-protein$ ${\underline{I}}nteraction$) assay was firmly demonstrated with FKBP12/FRB interaction induced by rapamycin within seconds in real-time analysis of living cells, indicating its recapitulation of physiological PPI dynamics. In addition, we applied p53/MDM2 interaction and its dissociation by Nutlin-3 to SeePPI assay and further confirmed that SeePPI was quantitative and well reflected the endogenous PPI. Our SeePPI assay will provide another useful tool to achieve an efficient analysis of PPIs and their modulators in cells.
Keywords
P-body; PPI modulator; Protein-Protein interaction; Translocation-based PPI assay;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jung S, Choi M, Choi K et al (2017) Inactivation of human DGAT2 by oxidative stress on cysteine residues. PLoS One 12, e0181076   DOI
2 Scott DE, Bayly AR, Abell C and Skidmore J (2016) Small molecules, big targets: drug discovery faces the protein-protein interaction challenge. Nat Rev Drug Discov 15, 533-550   DOI
3 Gonzalez MW and Kann MG (2012) Chapter 4: Protein interactions and disease. PLoS Comput Biol 8, e1002819   DOI
4 Lee S, Ha JS, Lee SG and Kim TK (2012) Inducible biosynthetic nanoscaffolds as recruitment platforms for detecting molecular target interactions inside living cells. J Am Chem Soc 134, 11346-11349   DOI
5 Kerppola TK (2008) Bimolecular fluorescence complementation (BiFC) analysis as a probe of protein interactions in living cells. Annu Rev Biophys 37, 465-487   DOI
6 Lee KB, Hwang JM, Choi IS et al (2011) Direct monitoring of the inhibition of protein-protein interactions in cells by translocation of PKCdelta fusion proteins. Angew Chem Int Ed Engl 50, 1314-1317   DOI
7 Lee KH, Lee S, Lee WY, Yang HW and Heo WD (2010) Visualizing dynamic interaction between calmodulin and calmodulin-related kinases via a monitoring method in live mammalian cells. Proc Natl Acad Sci U S A 107, 3412-3417   DOI
8 Aizer A, Brody Y, Ler LW, Sonenberg N, Singer RH and Shav-Tal Y (2008) The dynamics of mammalian P body transport, assembly, and disassembly in vivo. Mol Biol Cell 19, 4154-4166   DOI
9 Kedersha N, Stoecklin G, Ayodele M et al (2005) Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 169, 871-884   DOI
10 Marchi S, Patergnani S and Pinton P (2014) The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. Biochim Biophys Acta 1837, 461-469   DOI
11 DeRose R, Miyamoto T and Inoue T (2013) Manipulating signaling at will: chemically-inducible dimerization (CID) techniques resolve problems in cell biology. Pflugers Arch 465, 409-417   DOI
12 Smith JJ and Aitchison JD (2013) Peroxisomes take shape. Nat Rev Mol Cell Biol 14, 803-817   DOI
13 Jares-Erijman EA and Jovin TM (2003) FRET imaging. Nat Biotechnol 21, 1387-1395   DOI
14 Fletcher S and Hamilton AD (2007) Protein-protein interaction inhibitors: small molecules from screening techniques. Curr Top Med Chem 7, 922-927   DOI
15 Zheng D, Ezzeddine N, Chen CY, Zhu W, He X and Shyu AB (2008) Deadenylation is prerequisite for P-body formation and mRNA decay in mammalian cells. J Cell Biol 182, 89-101   DOI
16 Franks TM and Lykke-Andersen J (2008) The control of mRNA decapping and P-body formation. Mol Cell 32, 605-615   DOI
17 Robida AM and Kerppola TK (2009) Bimolecular fluorescence complementation analysis of inducible protein interactions: effects of factors affecting protein folding on fluorescent protein fragment association. J Mol Biol 394, 391-409   DOI
18 Iwakuma T and Lozano G (2003) MDM2, an introduction. Mol Cancer Res 1, 993-1000
19 Shangary S and Wang S (2008) Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res 14, 5318-5324   DOI
20 Burgess A, Chia KM, Haupt S, Thomas D, Haupt Y and Lim E (2016) Clinical Overview of MDM2/X-Targeted Therapies. Front Oncol 6, 7
21 Kulikov R, Winter M and Blattner C (2006) Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. J Biol Chem 281, 28575-28583   DOI
22 Fry DC, Wartchow C, Graves B et al (2013) Deconstruction of a nutlin: dissecting the binding determinants of a potent protein-protein interaction inhibitor. ACS Med Chem Lett 4, 660-665   DOI
23 Wells JA and McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001-1009   DOI